Latest news
Loading news…
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Cidara Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Cidara Therapeutics was acquired by Merck in 2025 for $9.19B.
Total Funding
$1.23B
Funding Rounds
10
Last Funding
Acquisitions
0
Monthly Visits
Contacts
84
About Cidara Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
Cidara Therapeutics Funding Rounds
10 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Investor Names | Funding Stage | Org Industries | Org Hq City | Org Hq Country | Org Description | Org Number Of Employees | Org Website | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1–5 of 10Show
Page 1 / 2
Cidara Therapeutics Key People
CEO & President
EVP, Technical Operations
Chief Financial Officer & Chief Business Officer
Chief Operating Officer
Chief Development Officer
CBO
84
professional contacts at Cidara Therapeutics
Contact execs at Cidara Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Cidara Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.